DE69429364D1 - Verwendung von steroidderivaten als arzneimittel - Google Patents
Verwendung von steroidderivaten als arzneimittelInfo
- Publication number
- DE69429364D1 DE69429364D1 DE69429364T DE69429364T DE69429364D1 DE 69429364 D1 DE69429364 D1 DE 69429364D1 DE 69429364 T DE69429364 T DE 69429364T DE 69429364 T DE69429364 T DE 69429364T DE 69429364 D1 DE69429364 D1 DE 69429364D1
- Authority
- DE
- Germany
- Prior art keywords
- alpha
- iii
- compounds
- side chain
- steroid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1994/002397 WO1994020520A1 (en) | 1993-03-10 | 1994-03-10 | Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
PCT/US1994/010265 WO1995024415A1 (en) | 1994-03-10 | 1994-09-13 | Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69429364D1 true DE69429364D1 (de) | 2002-01-17 |
DE69429364T2 DE69429364T2 (de) | 2002-08-08 |
Family
ID=22242322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69429364T Expired - Lifetime DE69429364T2 (de) | 1994-03-10 | 1994-09-13 | Verwendung von steroidderivaten als arzneimittel |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0749437B1 (de) |
JP (1) | JPH09509959A (de) |
AT (1) | ATE210144T1 (de) |
CA (1) | CA2185123C (de) |
DE (1) | DE69429364T2 (de) |
DK (1) | DK0749437T3 (de) |
ES (1) | ES2164110T3 (de) |
PT (1) | PT749437E (de) |
WO (1) | WO1995024415A1 (de) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856535A (en) * | 1994-08-18 | 1999-01-05 | Magainin Pharmaceuticals, Inc. | Aminosterol ester compounds |
US5792635A (en) * | 1995-06-07 | 1998-08-11 | Magainin Pharmaceuticals, Inc. | Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine |
US6143738A (en) * | 1995-06-07 | 2000-11-07 | Magainin Pharmaceuticals, Inc. | Therapeutic uses for an aminosterol compound |
US6596712B2 (en) | 1996-04-26 | 2003-07-22 | Genaera Corporation | Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities |
DK0910382T3 (da) * | 1996-04-26 | 2003-10-06 | Genaera Corp | Squalamin i kombination med andre anticancermidler til behandling af tumorer |
US7410959B1 (en) | 2000-07-13 | 2008-08-12 | Genaera Corporation | Therapeutic uses for aminosterol compounds |
AU5194998A (en) * | 1996-11-01 | 1998-05-29 | Magainin Pharmaceuticals, Inc. | Certain aminosterol compounds and uses therefor |
US6262283B1 (en) | 1996-12-06 | 2001-07-17 | Magainin Pharmaceuticals Inc. | Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds |
US6767904B2 (en) | 1998-03-06 | 2004-07-27 | Bringham Young University | Steroid derived antibiotics |
US6350738B1 (en) | 1998-03-06 | 2002-02-26 | Brigham Young University | Steroid derived antibiotics |
EP1058552B1 (de) * | 1998-03-06 | 2004-06-16 | Brigham Young University | Antibiotische steroidderivate |
ATE342912T1 (de) | 2000-04-12 | 2006-11-15 | Genaera Corp | Ein verfahren zur herstellung von 7.alpha.- hydroxy 3-aminosubstituierten sterol-verbindungen,ohne schutz der 7.alpha.-hydroxy-gruppe |
US9943614B2 (en) | 2008-06-17 | 2018-04-17 | Brigham Young University | Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods |
JP5147814B2 (ja) * | 2009-11-12 | 2013-02-20 | ブリガム・ヤング・ユニバーシティ | ステロイド由来抗生物質 |
WO2012122433A2 (en) | 2011-03-08 | 2012-09-13 | Staker & Parson Companies | Concrete mixtures including carbon encapsulating admixture |
BR112014001444A2 (pt) | 2011-07-20 | 2017-07-18 | Univ Brigham Young | compostos hidrofóbicos de ceragenina e dispositivos que incorporam os mesmos |
US8932614B2 (en) | 2011-08-25 | 2015-01-13 | Paul B. Savage | Incorporation of particulate ceragenins in polymers |
CA2852989C (en) | 2011-09-13 | 2021-06-29 | Brigham Young University | Compositions for treating bone diseases and broken bones |
US9603859B2 (en) | 2011-09-13 | 2017-03-28 | Brigham Young University | Methods and products for increasing the rate of healing of tissue wounds |
US9694019B2 (en) | 2011-09-13 | 2017-07-04 | Brigham Young University | Compositions and methods for treating bone diseases and broken bones |
AU2012308530B2 (en) * | 2011-09-13 | 2016-04-21 | Brigham Young University | Products for healing of tissue wounds |
MX2014007496A (es) | 2011-12-21 | 2015-02-17 | Univ Brigham Young | Composiciones para el cuidado oral. |
US9533063B1 (en) | 2012-03-01 | 2017-01-03 | Brigham Young University | Aerosols incorporating ceragenin compounds and methods of use thereof |
EP2846634A2 (de) | 2012-05-02 | 2015-03-18 | Brigham Young University | Partikelförmige cerageninmaterialien und verfahren zur herstellung davon |
WO2014062960A1 (en) | 2012-10-17 | 2014-04-24 | Brigham Young University | Treatment and prevention of mastitis |
EP2941253B1 (de) | 2013-01-07 | 2021-08-11 | Brigham Young University | Antimikrobielle kationische steroide zur behandlung von krebs |
US11524015B2 (en) | 2013-03-15 | 2022-12-13 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US10568893B2 (en) | 2013-03-15 | 2020-02-25 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
CA2907082C (en) | 2013-03-15 | 2021-05-04 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
US9387215B2 (en) | 2013-04-22 | 2016-07-12 | Brigham Young University | Animal feed including cationic cholesterol additive and related methods |
US11690855B2 (en) | 2013-10-17 | 2023-07-04 | Brigham Young University | Methods for treating lung infections and inflammation |
US20150203527A1 (en) | 2014-01-23 | 2015-07-23 | Brigham Young University | Cationic steroidal antimicrobials |
CA2844321C (en) | 2014-02-27 | 2021-03-16 | Brigham Young University | Cationic steroidal antimicrobial compounds |
US10220045B2 (en) | 2014-03-13 | 2019-03-05 | Brigham Young University | Compositions and methods for forming stabilized compositions with reduced CSA agglomeration |
US9867836B2 (en) | 2014-03-13 | 2018-01-16 | Brigham Young University | Lavage and/or infusion using CSA compounds for increasing fertility in a mammal |
US9931350B2 (en) | 2014-03-14 | 2018-04-03 | Brigham Young University | Anti-infective and osteogenic compositions and methods of use |
US9686966B2 (en) | 2014-04-30 | 2017-06-27 | Brigham Young University | Methods and apparatus for cleaning or disinfecting a water delivery system |
US10441595B2 (en) | 2014-06-26 | 2019-10-15 | Brigham Young University | Methods for treating fungal infections |
US10238665B2 (en) | 2014-06-26 | 2019-03-26 | Brigham Young University | Methods for treating fungal infections |
US10227376B2 (en) | 2014-08-22 | 2019-03-12 | Brigham Young University | Radiolabeled cationic steroid antimicrobials and diagnostic methods |
US10155788B2 (en) | 2014-10-07 | 2018-12-18 | Brigham Young University | Cationic steroidal antimicrobial prodrug compositions and uses thereof |
WO2016172553A1 (en) | 2015-04-22 | 2016-10-27 | Savage Paul B | Methods for the synthesis of ceragenins |
US10370403B2 (en) | 2015-04-22 | 2019-08-06 | Brigham Young University | Methods for the synthesis of ceragenins |
US9434759B1 (en) | 2015-05-18 | 2016-09-06 | Brigham Young University | Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds |
US10226550B2 (en) | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
US10959433B2 (en) | 2017-03-21 | 2021-03-30 | Brigham Young University | Use of cationic steroidal antimicrobials for sporicidal activity |
CN108445236B (zh) * | 2018-02-07 | 2021-04-20 | 深圳市新产业生物医学工程股份有限公司 | 甾体类衍生物和其保存液以及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3370070A (en) * | 1965-06-16 | 1968-02-20 | Searle & Co | [n-alkyl-17-(dialkylaminoalkyl)amino] androst-4-en-3-ones |
GB1565351A (en) * | 1975-06-02 | 1980-04-16 | Theramex | Steroid aminoethers |
US5004737A (en) * | 1989-09-22 | 1991-04-02 | Pacific Chemical Co., Ltd. | Quaternary ammonium-substituted sterol derivatives |
US5192756A (en) * | 1992-03-18 | 1993-03-09 | The Children's Hospital Of Pennsylvania | Aminosterol antibiotic |
-
1994
- 1994-09-13 EP EP94931274A patent/EP0749437B1/de not_active Expired - Lifetime
- 1994-09-13 JP JP7523429A patent/JPH09509959A/ja not_active Ceased
- 1994-09-13 DK DK94931274T patent/DK0749437T3/da active
- 1994-09-13 AT AT94931274T patent/ATE210144T1/de not_active IP Right Cessation
- 1994-09-13 PT PT94931274T patent/PT749437E/pt unknown
- 1994-09-13 WO PCT/US1994/010265 patent/WO1995024415A1/en active IP Right Grant
- 1994-09-13 ES ES94931274T patent/ES2164110T3/es not_active Expired - Lifetime
- 1994-09-13 CA CA2185123A patent/CA2185123C/en not_active Expired - Lifetime
- 1994-09-13 DE DE69429364T patent/DE69429364T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0749437A1 (de) | 1996-12-27 |
JPH09509959A (ja) | 1997-10-07 |
ATE210144T1 (de) | 2001-12-15 |
WO1995024415A1 (en) | 1995-09-14 |
CA2185123C (en) | 2010-11-16 |
DE69429364T2 (de) | 2002-08-08 |
CA2185123A1 (en) | 1995-09-14 |
AU8010194A (en) | 1995-09-25 |
DK0749437T3 (da) | 2002-03-04 |
EP0749437B1 (de) | 2001-12-05 |
PT749437E (pt) | 2002-03-28 |
AU700344B2 (en) | 1998-12-24 |
ES2164110T3 (es) | 2002-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69429364D1 (de) | Verwendung von steroidderivaten als arzneimittel | |
DE69412596D1 (de) | Steroidderivate, pharmazeutische zusammensetzungen die sie enthalten und ihre verwendung als antibiotika oder desinfektionsmittel | |
CA2157117A1 (en) | Spirocyclic Piperidine Derivatives | |
CA2134964A1 (en) | Bridged Aza-Bicyclic Derivatives as Substance P Antagonists | |
HK1016177A1 (en) | New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency | |
AU2685192A (en) | Nitrogenous heterocyclic compound | |
FI935529A (fi) | Aminometylensubstituerade icke-aromatiska heterocykliska foereningar | |
DE69609912T2 (de) | Harnstoff- und Amid-Derivate mit ACAT-Inhibitorwirkung, ihre Herstellung und ihre therapeutische und prophylaktische Verwendung | |
ATE82966T1 (de) | Pyridincarboxamid-derivate und ihre verwendung als fungizides mittel. | |
DE69111029T2 (de) | Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung. | |
PT83961A (de) | Pyrazolin-derivate ihre herstellung und ihre verwendung als mittel mit insektizider und akarizider wirkung | |
ATE117681T1 (de) | Chinolinderivate, ihre herstellung und verwendung. | |
MX9300222A (es) | Nuevos derivados de arilcicloalquilo, su preparacion y su utilizacion. | |
CA2114727A1 (en) | Quinoline Derivatives as Immunostimulants | |
DE69311165D1 (de) | Kondensierte heterocyclische Ketonderivate, ihre Herstellung und ihre Verwendung | |
BG96171A (bg) | Амидинофенилаланинови производни,метод за получаването им, приложението им и средства,които ги съдържат | |
ATE51624T1 (de) | Carbapenemverbindungen, deren herstellung und verwendung. | |
EA199700288A1 (ru) | Таксоиды, способы их получения и фармацевтическая композиция на их основе | |
DK56687A (da) | 5-substitueret octahydroindolizinforbindelser samt 7-ketomellemprodukter ved fremstillingen heraf | |
ES537805A0 (es) | Un derivado de acetileno | |
EP0230474A4 (de) | Bis-dioxopiperazinabkömmlinge und arzneimittel daraus. | |
DE69601451T2 (de) | UCK14-Verbindungen | |
ATE15184T1 (de) | Fluorphenoxybenzylester, ihre herstellung und ihre verwendung als schaedlingsbekaempfungsmittel. | |
CA2171972A1 (en) | Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds | |
DE69501810D1 (de) | Verwendung von 5-Thia-1,4-Diazabicyclo [4.2.0] Octane-3,8-dioxo Verbindungen in der Antitumor-Therapie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |